# Revisiting Centiloids using AI

**Authors:** Pierrick Bourgeat, Jurgen Fripp, Leo Lebrat, Ying Xia, Azadeh Feizpour, Timothy Cox, Georgios Zisis, Ashley Gillman, Manu Goyal, Duygu Tosun, Tammie Benzinger, Pamela LaMontagne, Michael Breakspear, Michelle Lupton, Cathy Short, Robert Adam, Joanne Robertson, Reisa Sperling, Sid O’Bryant, Sterling Johnson, Clifford Jack, Christopher Schwarz, Denise (C) Park, Frederik Barkhof, Gill Farrar, Ariane Bollack, Lyduine Collij, Susan Landau, Robert Koeppe, John Morris, Michael Weiner, Victor Villemagne, Colin Masters, Christopher Rowe, Vincent Doré

PMC · DOI: 10.21203/rs.3.rs-7015694/v1 · Research Square · 2025-07-08

## TL;DR

This paper introduces DeepSUVR, an AI method that improves the accuracy and consistency of amyloid PET scans, which are used to study Alzheimer's disease.

## Contribution

DeepSUVR is a novel deep learning method that corrects Centiloid quantification by penalizing implausible longitudinal trajectories.

## Key findings

- DeepSUVR increased correlation between tracers and reduced variability in Aβ-negative scans.
- It showed the strongest association with cognition and best longitudinal consistency across studies.
- DeepSUVR increased the effect size for detecting lower Centiloid increase per year in the A4 study.

## Abstract

The Centiloid scale is the standard for Amyloid (Aβ) PET quantification, widely used in research, clinical settings, and trial stratification. However, variability between tracers and scanners remains a challenge. This study introduces DeepSUVR, a deep learning method to correct Centiloid quantification, by penalising implausible longitudinal trajectories during training. The model was trained using data from 2,098 participants (6,762 Aβ PET scans) in AIBL/ADNI and validated using 15,806 Aβ PET scans from 10,543 participants across 10 external datasets. DeepSUVR increased correlation between tracers, and reduced variability in the Aβ-negatives. It showed the strongest association with cognition, highest AUC against visual reads and best longitudinal consistency between studies. DeepSUVR also increased the effect size for detecting lower Centiloid increase per year in the A4 study. DeepSUVR advances Aβ PET quantification, outperforming standard approaches, which is particularly important for consistent decision making and to detect subtle and early changes in clinical interventions.

## Linked entities

- **Diseases:** Alzheimer's disease (MONDO:0004975)

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Chemicals:** Centiloids (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12265171/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12265171/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12265171/full.md

---
Source: https://tomesphere.com/paper/PMC12265171